Home » Newsletters » BioWorld Asia

BioWorld Asia

July 7, 1999

View Archived Issues

Bristol-Myers Squibb Exits Alliance With Neurosearch

Malarial Parasite Interferes With Response To Infection

Alizyme Plans #12.3 Placement To Fund Portfolio Development

Newly Cloned Heparanase Inhibits Cancer Metastases

Cortecs Reduces Staff, Burn As Company Changes Focus

British Biotech Plots New Course Following Setbacks

Transghne Starts Phase I Of Interferon Gene Therapy

European Researchers Team Up To Study Genes In Rheumatism

Biological Glue Takes The Bite Out Of Bullet

CAT Settles Patent Dispute Relating To Gene Library

Biocrystallization Of DNA Protects Against Stress

Xenova Group Brings In #6.1M

Gensets Cohen Wins Golden Plate

Pharming Prepares To Take Lactoferrin Into The Clinic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...